Genetically identical organisms in homogeneous environments have different lifespans and healthspans. These differences are often attributed to stochastic events, such as mutations and 'epimutations', changes in DNA methylation and chromatin that change gene function and expression. But work in the last 10 years has revealed differences in lifespan-and health-related phenotypes that are not caused by lasting changes in DNA or identified by modifications to DNA or chromatin. This work has demonstrated persistent differences in single-cell and wholeorganism physiological states operationally defined by values of reporter gene signals in living cells. While some single-cell states, for example, responses to oxygen deprivation, were defined previously, others, such as a generally heightened ability to make proteins, were, revealed by direct experiment only recently, and are not well understood. Here, we review technical progress that promises to greatly increase the number of these measurable single-cell physiological variables and measureable states. We discuss concepts that facilitate use of single-cell measurements to provide insight into physiological states and state transitions. We assert that researchers will use this information to relate cell level physiological readouts to whole-organism outcomes, to stratify aging populations into groups based on different physiologies, to define biomarkers predictive of outcomes, and to shed light on the molecular processes that bring about different individual physiologies. For these reasons, quantitative study of single-cell physiological variables and state transitions should provide a valuable complement to genetic and molecular explanations of how organisms age.
Background: stochastic events and biological outcomes
Lifespan and its newer (and obscurely begotten; Rivlin, 1992) cousin, healthspan, measurable in units of time (or even Quality Adjusted Life Years; Kaplan, 1993) are prime examples of complex quantitative phenotypes not simply determined by genotype and environment. Genetically identical Saccharomyces cerevisiae and Caenorhabditis elegans raised in homogeneous environments have different lifespans (Mortimer & Johnston, 1959; Klass, 1977; Kirkwood & Finch, 2002) ; in both organisms, the difference in the age between the first and last deaths in small populations can be more than fivefold. Similarly, human monozygotic twins, raised in similar environments, have different lifespans (Herskind et al., 1996) . Genetically identical organisms also show different healthspans. For example, human twins of the same age show differences in various tests of strength (Arden & Spector, 1997; Silventoinen et al., 2008) . In middle adulthood, some isogenic worms in homogenous environments are immobile, whereas others move around youthfully (Hosono et al., 1980; Herndon et al., 2002) . Moreover, in isogenic populations, interindividual differences in other quantitative phenotypes that measure healthspan increase with age (Kirkwood & Finch, 2000; Herndon et al., 2002) .
Broadly speaking, the observed variation in lifespan and increased variation in health over time is consistent with the idea that decline in health after maturity and eventual death by old age are the consequence of random events (Kirkwood & Finch, 2000; Hayflick, 2007) . In this view, cell and organismic death the end result of the progressive loss of function caused by chains of these events, and the fact that these the multiple events occur randomly causes cells and animals to become more physiologically distinct with age (Martin, 2009) . In this review, we emphasize this view in contrast to the idea that events during decline and aging are the result of the workings of an explicit genetic program such that which governs metazoan development.
For lifespan, healthspan, and other complex quantitative phenotypes, researchers normally deploy the word 'stochastic' to denote nonenvironmental, nongenetic causes of differences (Kliebenstein, 2011 ) that they do not otherwise understand. When researchers in the aging field have studied stochastic differences in lifespan and healthspan, they have frequently examined lasting changes caused by mutations (Strehler, 1986; Melov et al., 1995 Melov et al., , 1999 Vijg & Suh, 2013) and 'epimutations': (e.g., changes in DNA methylation, Fraga et al., 2005; Greer et al., 2015;  and/or histone modifications, Greer et al., 2010) . It seems possible that some of this emphasis on mutations and epimutations as causal may have been due to the very power of the methods, some general, some of which were specifically and cleverly devised, allowing detection of agingrelated changes in DNA and chromatin. We imagine that additional kinds of stochastic events that might contribute to aging. For example, consider differential segregation of regulatory molecules or molecular complexes present in small number (Delbr€ uck, 1940 (Delbr€ uck, , 1945 Spudich & Koshland, 1976) and spontaneous or signal-triggered changes in conformation of proteins that form aggregates affecting cell function (Cox, 1971; Jarosz et al., 2014a,b) or causing cell toxicity (Morley et al., 2002; Brignull et al., 2006) . In that spirit, we review recent technical and conceptual progress that should enable a complementary experimental approach. It has now become possible to observe and quantify changes in physiology and in physiological state in living single cells in intact animals over time. This newfound ability will allow ordering of events and changes of cell state as animals age, definition of the cell-and organism-level consequences of the changes in cell function, and suggest testable hypotheses for the molecular mechanisms that bring these about, without prior assumptions as to causation.
The complementary concept of physiological states
In this review, we will build on an older, premolecular picture of biological function, one we believe may be particularly relevant to an understanding of aging. In this view, biological systems, including cells and organisms, exist in discrete physiological states. These states are defined by different combinations of observable characteristics that persist over time. Causal events, which include all of the different stochastic events mentioned above, but whose nature does not need to be specified, can induce the system to make a transition from one physiological state to a different state. This new state again tends to persist over time, until transition to another state. The temporal progression of biological systems, during postembryonic-developmental aging, or in response to defined events that affect function, can thus be viewed as a set of transitions from state to state. In medicine, this view is partly explicit in work of Cannon (Cannon 1929) .
Here, we develop and use a framework and vocabulary (Box 1) for describing these physiological states and state transitions. This roots of the framework are work by 19th and early 20th century physicists, who realized that changes in the values of variables representing different properties of dynamical systems over time could define trajectories through a high-dimensional space (Gibbs, 1902; Nolte, 2010) . Subsequently, the use of values of variables representing properties of systems, and the metaphor that these systems described trajectories through high-dimensional phase spaces or state spaces over time, came to be used in disciplines as diverse as engineering and meteorology (Lorenz, 1963) . Significantly, this framework represents and first focuses on of the states, state transitions, and trajectories, and the consequences of these things, rather than on their causes.
One application of such thinking to whole-organism physiology came from work in the 1970s by a group of physicians Siegel et al. (1974 Siegel et al. ( , 1979 . They used measurable quantities (e.g., cardiac output, heart rate) in critically ill patients after surgery, and plotted their values in highdimensional space. They used ranges of values of these variables to define five prototype states (Siegel et al., 1979) . For different patients, the values of these variables over time described different, stereotyped trajectories from cluster to cluster, or state to state, as those patients recovered, or as they became sicker and died. Later, Rixen et al. (1996) showed that patients in septic shock moved between seven physiological states defined by 17 measured variables, and that different patients followed particular 'routes' between these states. Figure 1 shows a general illustration of this concept applied to human disease states. It shows different prototypical states, in a physiological state space defined by only three variables, and potential trajectories described by different patients making transitions between these states. This framework thus naturally represents changes in system function over time.
Newfound abilities to monitor physiological states in single cells
The trigger for this review is the fact that, enabled by the development of fluorescent proteins, it is now possible to observe and quantify physiological variables in single cells in living organisms over time (Mendenhall et al., 2015) . Table 1 shows different classes of physiological variables that are now quantifiable by such means. These include variables whose values are continuous and that define 'classical' physiological quantities; consider, for example, pH or redox. They also include variables whose values are integer quantities; for example, consider the number of unrepaired double-stranded DNA ends a cell has (quantified by punctate signal from a fluorescent derivative of the bacteriophage Mu gamma protein; Shee et al., 2013) . These variables also include measures of quantities only defined by new discovery. Consider, for example, the conceivable single-cell variables measuring cell nutritional and growth factor status, now definable by live cell measurement of activity of the mTORC1 complex (Table 1) . Twenty five years ago, Tor (Brown et al., 1994) and the mTORC complexes were • In some cases, over time, the trajectories of cells and organisms described can be considered as movement from one basin of attraction to another.
• Some physiological variables measure, and some physiological states reflect, cellular pathologies.
• We refer to a trajectory through physiological state space that traverses multiple states associated with cellular pathologies as a decline path. A decline path that ends in cell death is a failure path. A decline path that ends in organism death is a fatality path.
unknown, and researchers could not have thought to measure variables that depended on cellular mTORC1 function until the relevant molecules nor their functions has been described. Finally, this also includes 'systems level' variables (e.g., G, which measures the general ability of a cell to express proteins; Colman-Lerner et al., 2005), which were previously unknown (Table 1) . Such variables are computed from measurements of multiple reporters in single cells. Some of the physiological states defined by ranges of values of these variables are consequential (see below). The technical ability to quantify classical and new physiological variables over time is well matched with representation and analysis via a modest generalization and extension of the state space metaphor. We detail this generalization in the Box 1. Five aspects of this generalization merit mention here. First, any given physiological variable may or may not be pertinent to the understanding of a given process, but many quantities are easy to measure, and, once measured, their values defines a coordinates on one axis in a higher dimensional space. Second, a researcher can, at will, define a range of values for a single variable or set of variables as a physiological state (e.g., the range of values of pH lower than 6.5 can define a cellular state of extreme acidity). Third, even without the guidance of researchers, measurements of physiological variables can themselves define different physiological states. Such states become apparent as clusters of values of variables within given ranges, common to many different cells or organisms, and/or maintained by the same cells or organisms over time. We can refer to either sort of cluster as a basin of attraction in the state space. Fourth, changes in the values of these variables over time define trajectories in the state space, including (pertinent to morbidity and aging) decline paths and failure paths (Box 1). Fifth, the state space representation says nothing about causes (stochastic or otherwise) of the state transitions, nor about mechanisms (molecular or otherwise) by which the values of variables that define given states are maintained. In this representation, it is the states, state transitions, and trajectories among the states that are the objects of first-order study -not the particular molecular mechanisms that bring these about.
We review below a number of ways in which this newly possible study of cell physiological states, state transitions, and trajectories, and their relation to whole-organism measures of physiology, has the potential to complement existing genetic and molecular pictures of organismic aging, and to guide new research.
Quantification of reporter outputs in living single cells can define 'systems level' physiological states
Knowledge of some of the new single-cell and whole-organism physiological states did not come from testing of previous hypothesis, but rather directly from consideration of experimental data. One set of insights came from our studies of a particular signal transmission pathway in single yeast cells (Colman-Lerner et al., 2005) , the S. cerevisiae pheromone response system. These experiments depended on the development of accurate means to quantify reporter signal from cells with low-measurement error (Gordon et al., 2007) , including accounting for different rates of fluorophore maturation and inhibition of cell cycle progression to eliminate that source of variability. By measuring fluorescent signal from pheromone-inducible reporter genes and from control reporter genes, in homogenous cultures of isogenic cells, in which cell cycle progression had been arrested, we quantified different sources of variation in cell signaling and in response. Importantly, only a small proportion of total cell-to-cell variation was caused by random fluctuations in gene transcription and translation ('expression noise' or 'intrinsic noise', c). Instead, cell-to-cell variation in signaling and response was dominated by differences in the capacity of individual cells to On single cell physiological states, Mendenhall et al. transmit signals through the pathway ('pathway capacity', P) and to express proteins from genes ('expression capacity', G). We encountered G when we found that the amount of fluorescent signal from the pheromone-induced reporter was highly correlated with that from control, constitutive promoters. Cell-to-cell variation in the correlated ability of isogenic cells to express different reporters defined cell-to-cell differences in G (Fig. 2) . Cells with high G expressed proteins at a higher rate and increased in volume more rapidly. Differences in G persisted for many hours. G thus defined a hitherto undefined single-cell physiological variable, and to define cells within a given range of values of G as being in a particular, persistent physiological state. Additional insights came from our work in C. elegans (Rea et al., 2005; Mendenhall et al., 2012;  Fig. 3 ). In 2005, Rea et al. studied isogenic worms raised in the same environment that carried a reporter gene in which the hsp-16.2 promoter drove synthesis of GFP (here, P hsp-16.2 ::gfp). Young adult animals differed greatly in the amount of green fluorescent signal they showed after a heat shock. This difference was consequential: bright green worms lived longer and were more resistant to subsequent stress. The authors suggested that differences in the amount of HSP-16.2 protein itself were 'probably not responsible for the observed differences in survival but that the differences in fluorescence probably reflected a hidden, heterogeneous, but now quantifiable, physiological state that dictates the ability of an organism to deal with the rigors of living.'
Our subsequent studies showed that the bulk of the fluorescent signal came from the 20 individual cells (Seewald et al., 2010) . Subsequent work to develop low measurement error methods for single cells showed that the reporter signal could be quantified in individual cells in anesthetized live animals (Mendenhall et al., 2015; Fig. 4) . This work confirmed the correlation between the state of high GFP expression in young adulthood and lifespan (Mendenhall et al., 2012) and identified a difference in healthspan (Cypser et al., 2013) ; animals in the state defined by high GFP expression in young adulthood showed more motility at a given age. This work thus defined a physiological variable, P hsp-16.2 -GFP-signal, whose value in turn defined a physiological state, measurable in single cells, which correlates with healthspan. This state of high expression was heritable (Cypser et al., 2013) and may be due to the same organism-to-organism differences in G observed in S. cerevisiae.
Quantification of existing fluorescent reporter outputs allows single-cell measurement of numerous additional physiological states
In addition to these 'systems level' single-cell physiological variables, different kinds of reporters now allow quantification of numerous additional physiological variables in living single cells. Important classes of reporters now include:
Reporters that quantify induction of gene expression by fluorescent protein signal. In the experiments that correlated the expression of the P hsp-16.2 ::gfp reporter with lifespan, quantification of the physiological variable depended on a reporter in which production of a particular inducible promoter drove synthesis of the fluorescent protein. A large number of such 'promoter fusion' or 'transcriptional' reporters for physiological variables thought to be relevant to aging already exist; for example, reporters for reactive oxygen species in C. elegans, in which the sod-3 superoxide dismutase promoter drives synthesis of GFP (Henderson et al., 2006 Larson, 2015) . We imagine that this direct RNA quantification will be applied to measure outputs from inducible promoters in single cells of C. elegans and other multicellular model organisms now used in aging research.
Reporters that quantify cellular events by changes in the subcellular localization of fluorescent protein signal. Consider a fusion protein comprised of the C. elegans FOXO3 homolog, daf-16 (Henderson & Johnson, 2001 ) and a fluorescent protein moiety. Upon stimulation with insulin-like growth factors or whole-animal treatments that induce insulin-like growth factor signaling, FOXO3/DAF-16 is excluded from the nucleus (Datta et al., 1999; Henderson & Johnson, 2001 ). The ratio of nuclear localized to cytoplasmic FOXO3 fusion proteins thus provides a real-time measure of the amount of insulin signaling. Such use of protein movement to different subcellular locations to quantify signaling events precisely is now very well established in yeast and mammalian cells (Datta et al., 1999; Cai et al., 2008; Baltanas et al., 2013; Blaustein et al., 2013; . Reporters that quantify 'classical' and 'new' physiological variables by changes in emission or excitation fluorescence spectra. The last 10 years has seen a great deal of work developing fluorescent protein derivatives in which the proteins themselves are the reporters. In these proteins, changes in fluorescent resonance energy transfer in dual fluorophore proteins, or changes in the spectrum of light emitted by single fluorophore proteins, can quantify a number of 'classical' cell physiological variables. Incorporation of appropriate localization moieties into such proteins allows them to quantify these variables in different subcellular locations and compartments. 'Simple' variables that can be quantified by such fluorescent protein reporters include pH (pHlourin and super ecliptic pHlourins (Miesenbock et al., 1998) , pHRed ), redox states (e.g., Grx1-roGFP2 to quantify GSH/GSSG redox; Gutscher et al., 2008) , level of H 2 0 2 (HyPer; Lukyanov & Belousov, 2014) , levels of calcium (Zhao et al., 2011) , ATP/ADP ratio (Berg et al., 2009) , and the ratio of NAD+/NADH . As mentioned, the development of sensors that respond to the activity of newfound molecules has also opened the way to definition and measurement, in single cells, of aging-relevant variables that 20 years ago were unknown. For example, the discovery of the metazoan mTORC1 (Kim et al., 2002) complex enabled the development of sensor molecules for its activity (Zhou et al., 2015) . The development of such sensors makes it possible to define and quantify variables related to mTORC1 activity such as: nutritional-mTORC1-status and growth-factor-dependent-mTORC1-status. The values of these two new variables would reflect, respectively, cellular nutrient supply, and stimulation by extracellular growth factors, and would change in response to inhibition by drugs such as rapamycin.
Advances in gene technology and image cytometry support better live-cell measurement of states
At the same time as the above developments demonstrate the relatively broad scope now available to design reporters to quantify additional physiological variables, other technical advances have made it easier to assemble DNA for new reporter constructs, to make transgenic organisms that contain the constructs, and quantify reporter output. Rapid assembly of reporter constructs is aided by improved in vitro DNA assembly methods and widespread adoption of construction by homologous recombination in yeast . Rapid construction of transgenic strains with well-behaved reporters in C. elegans has been greatly aided by the development of methods that allow integration of reporters at defined chromosomal sites (Frokjaer-Jensen et al., 2008) . Moreover, in all organisms, construction of well-defined reporter strains has been greatly aided by CRISPR/Cas9 methods that use engineered proteins and RNAs to direct DNA binding, nicking, and cleavage to defined sites throughout the genome (Frokjaer-Jensen, 2013; Doudna & Charpentier, 2014) .
Advances in microscopy and improvement in protein fluorophores have increased the sensitivity and accuracy with which physiological variables can be quantified. Key improvements include increasing use of fluorescent lifetime microscopy to quantify physiological variables (e.g., NADH) (Stringari et al., 2011) and to increase signal to noise (Zeug et al., 2012) , and steady improvement in means to illuminate the volume to be interrogated (Gao et al., 2014; Winter & Shroff, 2014; Chen et al., 2014) . They also include lower technology low-measurement-error microscopic methods to facilitate longitudinal measurement of the same set of variables from designated cells in an organism as an organism ages (Mendenhall et al., 2015) . Meanwhile, steady increases in the numbers of different emission maxima, excitation maxima; and fluorescent lifetimes of fluorescent proteins (Chudakov et al., 2010; Sands et al., 2014) have increased the numbers of distinguishable signals that can be quantified from the same cell. 
Maps of trajectories in state space might help frame quantitative single-cell physiological measurements as biological explanations
The above technological developments will enable collection of dozens of physiological variables from single cells in living animals. They will also allow its interpretation within the conceptual framework of highdimensional physiological state space. This framework provides means to view temporal progression, and so becomes more powerful when coupled to longitudinal measurements of the same cell or organism over time. Figure 4 shows a simple example of this, the collection (A and B) and plotting of (C) three variables from two cells in the intestine, before and after exposure of animals to ethanol. Figure 5 shows a more complex, hypothetical example. In this example, the difference in measured physiological variables for a particular cell in different animals increases with age. In this example, the increased variation is most marked in animals in a low-G physiological state.
For aging research, we believe this picture of the movement of cells in trajectories through physiological state space might be particularly appropriate. There are a number of reasons for our belief. One is that understanding of aging has developed sufficiently to permit listing of a finite number of processes believed to contribute to it (National Institute on Aging 2011; Lopez-Otin et al., 2013) . Defining and enumerating (are there few, or many?) common decline and failure paths in different cell types will allow ordering of their steps with respect to these known processes. A second is that longitudinal physiological studies of cells in aging organisms will enable experimentation (both hypothesis-directed and discovery-driven) to understand single-cell consequences of genetic and pharmacological interventions already known to alter wholeorganism lifespan and healthspan. A third is to enable and track experimentation designed to suggest or test hypotheses for additional molecules and molecular events responsible for entry into, maintenance within, and exit from, physiological states. Should additional molecular mechanisms be identified, researchers can use those to devise directed pharmacological or genetic interventions to manipulate the probability of state transitions, for purposes of prevention and therapy.
Single-cell physiological measurements should aid understanding of whole-organism phenotypes
We should be explicit as to how measurements of single-cell variables might inform studies of whole-organism physiology. The first way is that live cell measurements are nondestructive, and allow correlation of their values with whole-organism measurements at some later point. A second is that many of the variables described here, such as redox, or hypoxia, are quantified in single cells because that is the only way, or the most accurate way, to measure them. Values are then averaged from dozens or hundreds of cells to permit assertions about the physiological state of the cell population or whole organ. A third is the ability to learn more than is revealed by population averages. It has long been clear (Ferrell & Machleder, 1998) and is now a truism, that measurements from large numbers of single cells can reveal heterogeneity in values not apparent from whole-population (or whole organ) measures. Revealed heterogeneity (Bahar et al., 2006) may be particularly valuable to aging researchers, whose work (when it does not directly address mortality) is still particularly concerned with phenomena of pathology and morbidity. For example, suppose that the value of a particular variable was zero in some cells (widely distributed or spatially grouped) within an organ, and cells with a zero value were known to be on a trajectory associated with a particular kind of necrotic death. Such knowledge might provide insights into possible causes of organ failure not apparent from existing pathological criteria or from population measurements. Such quantitative knowledge might allow operational definition of state transitions now articulated in qualitative terms like 'tipping points' .
That said, we realize that defining relationships between the cell level variables associated with aging-related states and the organism-level variables that measure organismic health and lifespan will not always be easy. For example, in our own work with aging isogenic worms cultured in the same environments, we observed three motility response states (Herndon et al., 2002) . When touched, animals in state A moved sinusoidally away from a touch stimulus. Animals in state B reacted, but moved away nonsinusoidally, and only when prodded with a wire. Animals in state C did not move away from the stimulus but twitched at heads and/or tails. Animals in states B and C animals showed correlated changes in muscle cell ultrastructure. All animals followed the same trajectory (state A to state B or C, state B to state C and then to death), but the timing of state transitions and time in each state differed among individuals. These experiments thus defined whole-organism physiological states associated with decline in function, and demonstrated interindividual differences in the timing of state transitions that were not caused by differences in the animal's genetics or known environment and that correlated with changes in muscle cell ultrastructure in fixed cells from killed animals. But there the analysis stopped. No matter the sorts of relationship we might be interested in elucidating -whether temporal, causal, molecular, or simply ordinal, the linkage between the wholeorganism phenotype and the changes in fixed cells still remains unclear.
The obvious forward path is to combine single-cell and whole-animal measures in living animals over time. For example, in aging C. elegans, an increasing number of intestine cells lose DAPI-stainable DNA, whereas in daf-2 mutants, which live longer, more intestine cells retain DAPI-stainable DNA (McGee et al., 2011) . At the moment, no relationship, even a temporal or ordinal one, between intestine cell DNA loss and organismic death has been defined. Clearly, definition of such relationships must precede deeper explanations. Such deeper explanations will then require Fig. 3 : long-lived, bright, high G and short-lived, dim, low G. In this example, values for all three variables were lower in older animals. Moreover, cell-to-cell variation in the measured variables was higher in older animals, with the highest variation in the dim, low G group. In practice, future experiments will likely measure more than three variables per cell and statements about the trajectories defined by changes in values will be based not on inspection of plots but on computed changes in position in the appropriate high-dimensional space.
On single cell physiological states, Mendenhall et al. coupling knowledge of cell biology and with deep understanding of the biology of the whole organism (or, in humans, clinical insight) .
Although it will be difficult, we confess to finding the idea that investigators may soon possess numerous single-cell level physiological variables to relate to organism-level variables to be exciting. Such knowledge will aid hypothesis formation, and so guide molecular studies of how these states might exert their effects on those particular cell biological processes now viewed as fundamental to aging (National Institute on Aging 2011; Lopez-Otin et al., 2013). As mentioned, such knowledge should therefore help to suggest new molecular targets for pharmacological intervention or germline genetic manipulation. But even before such work could suggest targets, knowledge of the, values of physiological variables may help stratify health and disease states now thought to be the same. Studies in model organisms may define variables that affect the probability of particular state transitions; such variables will define new 'biomarkers' (Baker & Sprott, 1988) predictive of future outcomes. In humans, stratification via biomarker assay based on single-cell physiological variables might eventually guide preventive and therapeutic interventions tailored to the physiological states of particular patients. Put into different words, for individual patients, assay of physiological variables would provide a personalized data type to complement the personalized genomic and other 'big-data' types (Council, 2011) that are now envisioned as the basis for the development of a 'precision medicine' (Handelsman, 2015) .
Physiological understanding as a complement to genetic and molecular understanding
We write this 15 years into the 21st century. During the previous century, the study of aging made real progress. A large contribution to this increased understanding came from advances in genetic concepts and methods. These allowed controlled experiments to study the consequences of experimental interventions in populations of genetically identical organisms (Pearl, 1928) , and established lifespan and other defined phenomena associated with health as quantitative phenotypes. Later genetics, used in concert with the tools of molecular biology, allowed isolation of genes that affected lifespan (Klass, 1983; Friedman & Johnson, 1988) , and analysis of how the gene products caused the phenotypes (Ogg et al., 1997) . By analogy, advances in 21st century methods that allow rigorous definition of cell physiological states may now aid understanding of additional complex phenotypes pertinent to organismic health and lifespan. The prospects for using concepts and methods from near-future physiology to understand and eventually manipulate longevity and health now seem bright.
